Health Decisions Celebrates 20 Years of Adaptive Clinical Research

Global CRO has thrived for two decades on business platform of innovation, collaboration and efficiency (Durham, NC: March 19, 2009) Health Decisions (, a full-service clinical research organization (CRO) specializing in adaptive solutions for high-efficiency clinical development, celebrates 20 years of growth this year. Headquartered in Durham, North Carolina, Health Decisions pioneered the concept of agile clinical research, an advanced adaptive system that allows mid-course improvements to key trial activities, helping sponsors more efficiently manage clinical trials and shorten timelines. In the current economic recession, these services are becoming increasingly important to pharmaceutical, biotech and medical device companies that are looking to cut costs and increase revenue.

Health Decisions was founded by Dr. Michael Rosenberg in 1989 in pursuit of a single goal: to improve the efficiency of clinical research. “While working at the Centers for Disease Control, I realized that the typical clinical trial was entrenched in tedious, manual procedures,” said Rosenberg. “There was, and still is, a real opportunity for improvement. So, we developed the concept of agile clinical research – using adaptive processes and intelligent web-based tools to continuously monitor trends and trigger study improvements on a real-time basis.”

Health Decisions has completed Phase I-IV trials in all major therapeutic areas for leading biotech and pharmaceutical companies around the world. The company offers a full range of drug development services including project management, clinical services and medical writing, data management, biostatistics, quality management and regulatory compliance, and strategic consulting.

Over the past two decades, Health Decisions has grown from Rosenberg and two UNC graduate student assistants to a company of approximately 150 employees. “When we started, it was all about a lean, focused approach to doing things the right way,” said Rosenberg. “Our growth has always been stimulated directly by our clients’ needs, and we look forward to exploring new ways to improve their profitability and set new standards of excellence in clinical trials.” For sales and marketing information, please contact Mike Watson, Director of Business Development, by email at or by phone at 919 967-1111 x133.

For media information, please contact Katie Hendrick, Marketing Specialist, by email at or by phone at 919 967-1111 x116.

About Health Decisions

Health Decisions (, a global clinical research organization (CRO), leads the industry in trial efficiency. Through integrated technology and agile clinical development methods that apply adaptive principles to both trial design and operations, Health Decisions provides sponsors unprecedented transparency and control and produces results 10 - 25% faster than traditional approaches.

Health Decisions is headquartered in Durham, NC, with over twenty years of drug development experience in setting new standards of speed and accuracy for pharmaceutical, biotech and medical drug and device companies in Phase I-IV trials across all major therapy areas. For more information, please visit the company’s website at

Back to news